VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Accenture plc vs Amgen Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Accenture plc
ACN · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Accenture plc's moat claims, evidence, and risks.
View ACN analysisAmgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Amgen Inc. leads (70 / 100 vs 66 / 100 for Accenture plc).
- Segment focus: Accenture plc has 2 segments (50.4% in Consulting); Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines).
- Primary market structure: Competitive vs Competitive. Pricing power: n/a vs Moderate.
- Moat breadth: Accenture plc has 7 moat types across 3 domains; Amgen Inc. has 5 across 3.
Primary market context
Accenture plc
Consulting
Enterprise consulting (strategy, management, technology consulting and technology integration consulting)
Global
Enterprises and public sector organizations
Advisor and systems integrator / implementation partner
50.4%
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
Side-by-side metrics
Moat coverage
Shared moat types
Accenture plc strengths
Amgen Inc. strengths
Segment mix
Accenture plc segments
Full profile >Consulting
Competitive
Managed Services
Oligopoly
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.